Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Congenital Heart Defect Devices Market Forecast: What Value Will The Market Reach By 2030?#_x000D_
The market size for congenital heart defect devices has shown robust growth recently. It is anticipated to expand from $3.11 billion in 2025 to $3.34 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. This historical increase can be attributed to several factors including the rising prevalence of congenital heart defects, continuous advancements in pediatric cardiac surgery, improved survival rates for patients with congenital heart conditions, the expansion of specialized cardiac care centers, and an increased focus on early diagnosis of congenital defects._x000D_
_x000D_
The congenital heart defect devices market size is projected to experience robust growth in the upcoming years. It is anticipated to expand to $4.45 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.4%. This projected expansion during the forecast period can be attributed to an increased emphasis on early diagnosis and intervention, a rising need for minimally invasive pediatric cardiac treatments, wider access to advanced cardiac care in developing markets, a growing population of adults living with congenital heart disease, and continuous innovation in implantable cardiac devices. Significant trends over this period include the increasing adoption of minimally invasive congenital heart procedures, a greater use of transcatheter and implantable cardiac devices, an escalating focus on early-life and pediatric cardiac interventions, the expansion of device-based therapies for complex heart defects, and a heightened demand for long-term cardiac monitoring and support devices._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Congenital Heart Defect Devices Market Growth Backed By Core Demand Fundamentals#_x000D_
The market for congenital heart defect devices is anticipated to expand, driven by the rising volume of minimally invasive procedures. These procedures entail surgical interventions performed via small cuts or natural bodily orifices, frequently employing specialized instruments and methods to lessen injury and improve recuperation. This surge in minimally invasive procedures stems from technological progress, patients favoring less intrusive treatments, enhancements in surgical methods, and the advantages of shorter recovery periods and fewer complications. Congenital heart defect devices are employed in minimally invasive procedures, aiding in the diagnosis, therapy, and handling of cardiac anomalies through methods involving smaller cuts or catheter-guided interventions. An example supporting this is the data from June 2024, where the American Society of Plastic Surgeons, a US-based organization, reported that in 2023, plastic surgeries saw a 5% increase, and minimally invasive procedures grew by 7% year-over-year. Consequently, the growing adoption of minimally invasive procedures is a key factor propelling the congenital heart defect device market._x000D_
_x000D_
#Congenital Heart Defect Devices Market Segment Performance And Emerging Opportunities#_x000D_
The congenital heart defect devices market covered in this report is segmented – _x000D_
_x000D_
1) By Device Type: Catheters, Pacemakers, Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers, Implantable Cardioverter Defibrillators, Biventricular Devices, Implanted Cardiac Loop Recorders, Other Device Types _x000D_
2) By Defect Type: Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect, Tricuspid Atresia, Truncus Arteriosus, Other Defect Types_x000D_
3) By End user: Hospitals, Specialty Clinics, Academic And Research Institute, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Catheters: Balloon Catheters, Diagnostic Catheters, Guiding Catheters _x000D_
2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers _x000D_
3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds, Dual-Chamber Icds, Subcutaneous Icds _x000D_
4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers), Crt-D (Cardiac Resynchronization Therapy Defibrillators) _x000D_
5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders, Subcutaneous Implantable Loop Recorders_x000D_
6) By Other Device Types: Transcatheter Heart Valves, Ventricular Assist Devices (VADS)_x000D_
_x000D_
#Congenital Heart Defect Devices Market Growth Trends Reshaping The Competitive Landscape#_x000D_
Leading companies operating within the congenital heart defect devices market are adopting a strategic partnerships approach to develop innovative congenital heart defect devices. These strategic alliances support firms in the congenital heart defect devices sector by consolidating resources and expertise, enhancing research and development efforts, broadening market access, and accelerating commercialization. Ultimately, this collaborative approach stimulates innovation and drives growth across the industry. For instance, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, partnered with HeartX, an India-based MedTech firm, to improve patient care within the cardiovascular sector. Through this partnership, Sahajanand Medical Technologies (SMT) strengthens its position in the congenital heart defect (CHD) space by integrating HeartX’s innovative solutions, such as the JOVE VB Stent. This strategic alliance allows SMT to offer advanced CHD devices that enhance treatment efficacy, simplify procedures, and improve patient outcomes._x000D_
_x000D_
#Congenital Heart Defect Devices Market Key Players Shaping Industry Direction#_x000D_
Major companies operating in the congenital heart defect devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc _x000D_
_x000D_
#View The Full Congenital Heart Defect Devices Market Report:#_x000D_
_x000D_
#Congenital Heart Defect Devices Market Regional Analysis: Which Region Leads By Revenue?#_x000D_
North America was the largest region in the congenital heart defect devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.